Since cancer cells treated with this hybrid peptide were annexin V and caspase 3, 7 positive as assessed by flow cytometry, and this peptide also caused the loss of Hsp90 client proteins including survivin (Figure 4), we propose the mechanism of action of Antp-TPR peptide cancer cells killing as follows. The gene discussed is HSP90AA1; the disease is cancer.